A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Clinical trial NCT07229599 · RECRUITING
Trial details
- NCT number
- NCT07229599
- Sponsor
- Minghui Pharmaceutical (Hangzhou) Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2029-05-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.